능동 이식형 의료기기 시장 : 제품별, 최종 사용자별, 지역별

Global Active Implantable Medical Devices Market is estimated to be valued at USD 27.41 Bn in 2025 and is expected to reach USD 45.21 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.

Figure. Active Implantable Medical Devices Market Share (%), By Region 2025

Global active implantable medical devices market growth is driven by rising aging population and increasing prevalence of chronic diseases worldwide. Active implantable medical devices are battery-powered medical devices that are implanted inside the human body to treat various medical conditions. Some key active implantable medical devices include implantable cardioverter defibrillators (ICDs), neurostimulators, and implantable drug pumps. ICDs are extensively used to treat life-threatening cardiac conditions like tachycardia and ventricular fibrillation. Neurostimulators help in managing chronic pain as well as neurological disorders such as epilepsy and Parkinson's disease. Implantable drug pumps assist in effective localized drug delivery for conditions like cancer and arthritis. Ongoing medical advancement and growing focus on development of miniaturized and technologically advanced implantable devices can drive the active implantable medical devices market growth during the forecast period.

Market Dynamics:

Rising geriatric population base that is highly susceptible to chronic diseases, increasing demand for minimally invasive procedures, growing prevalence of cardiac disorders and neurological conditions can drive the global active implantable medical devices market growth. According to the United Nations, the population aged 60 years and above is projected to reach 2.1 billion globally by 2050 from 1 billion currently. Growing preference for implantable devices over conventional drug therapy and medical devices due to advantages such as long-term effectiveness and easy remote monitoring can boost adoption of active implantable medical devices. However, limited reimbursement coverage for high-cost implantable devices especially in developing nations, frequent product recalls owing to safety issues, and stringent regulatory approvals can hamper the market growth during the forecast period. Ongoing technological innovation in the field of robotics, bioprinting, 3D printing and development of miniature battery powered devices for long term implantation can offer growth opportunities for active implantable medical devices market players.

Key features of the study:

This report provides in-depth analysis of the global active implantable medical devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global active implantable medical devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Cochlear Ltd, Abbott, LivaNova PLC, Boston Scientific Corporation, Myomo, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global active implantable medical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global active implantable medical devices market

Detailed Segmentation-

• By Product
  • Implantable Cardioverter Defibrillators
  • Implantable Cardiac Pacemakers
  • Ventricular Assist Devices
  • Implantable Heart Monitors/Insertable Loop Recorders
  • Neurostimulators
  • Implantable Hearing Devices
  • Others
• By End Users
  • Hospitals
  • Ambulatory Surgery Center
  • Specialty Clinics
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • Biotronik SE & Co. KG
  • Cochlear Ltd.
  • William Demant Holding A/S
  • Sonova Holding AG
  • MED-EL
  • Nurotron Biotechnology Co. Ltd.
  • Zimmer Biomet Holdings, Inc.
  • Nevro Corp.
  • Second Sight Medical Products, Inc.
  • Nuvectra Corporation
  • Aleva Neurotherapeutics SA
  • Pixium Vision
  • Retina Implant AG
  • Corindus Vascular Robotics, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By End User
  • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Active Implantable Medical Devices Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Active Implantable Medical Devices Market, By Product, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Implantable Cardioverter Defibrillators
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Implantable Cardiac Pacemakers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ventricular Assist Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Implantable Heart Monitors/Insertable Loop Recorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurostimulators
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Implantable Hearing Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (fully-automatic vial-filling machine, etc.)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Active Implantable Medical Devices Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgery Center
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Active Implantable Medical Devices Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LivaNova PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Biotronik SE & Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cochlear Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • William Demant Holding A/S
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sonova Holding AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • MED-EL
  • Nurotron Biotechnology Co. Ltd.
  • Zimmer Biomet Holdings, Inc.
  • Nevro Corp.
  • Second Sight Medical Products, Inc.
  • Nuvectra Corporation
  • Aleva Neurotherapeutics SA
  • Pixium Vision
  • Retina Implant AG
  • Corindus Vascular Robotics, Inc.

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. Research Methodology

• References
• Research Methodology
• About us and Sales Contact